Ernexa Therapeutics Inc — Cash Flow (NASDAQ:ERNA) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics

Quarterly Annual

Cash from operating activities 3.89 M-23.49 M21 M20.4 M15.8 M 9.41 M Cash from investing activities 960 K22.74 M47 K19 K365 K 22 K Cash from financing activities 291 K61.59 M19.58 M16.56 M6.26 M 8.22 M Free cash flow 3.65 M-23.64 M20.7 M20.38 M15.43 M 9.39 M

Notizie

Proprietario del dieci percento di Ernexa Therapeutics, Cherington acquista azioni per 2 milioni di dollari

Ernexa therapeutics ten percent owner Cherington buys $2m in stock

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.47%

Programma commerciale giapponese seleziona Ernexa Therapeutics tra l’élite biotech

Japanese trade program selects Ernexa Therapeutics among elite biotech group

Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AAR (NYSE:AIR), Alpha Modus Holdings (NASDAQ:AMOD)

Ernexa receives FDA alignment for ovarian cancer cell therapy

Il titolo di Ernexa Therapeutics scende dopo la presentazione al meeting ASH

Ernexa Therapeutics stock falls after ASH meeting presentation

Ernexa reports promising preclinical data for cancer cell therapy

Ernexa Therapeutics nomina l’oncologo Dr. Winer nel comitato consultivo

Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board